Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Natco Pharma shares rise 4% on settlement order in US patent case over generic Ozempic
The strong up move was seen in the stock price with the scrip touching the day's high of Rs 1,408.70 per share on the NSE, rising 4 percent.
Mylan settles patent litigation with Novo Nordisk over generic Ozempic in United States
According to a report by news agency PTI, NATCO and Mylan have partnered for the development of generic Ozempic (Semaglutide) products, the company said in a regulatory filing. Ozempic is a prescription medication patented by Novo Nordisk.
Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic
Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US patent litigation concerning the drug, Natco Pharma informed the stock exchanges in a filing.
2d
on MSN
Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number ...
2h
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American ...
Richmond BizSense
3h
Richmond-based pharma company Kaleo laying off dozens of employees
The company described the move as a “mass layoff of its sales representatives and related employees across the country,” ...
India Infoline
1h
Natco Pharma settles US patent case over generic Ozempic
According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.
3h
The US wants to cut its reliance on Chinese pharma. These stocks could benefit.
On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...
15h
Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma
Kirk Spano and Bhavneesh Sharma talk biotech, pharma, and why complete response letters are a good contrarian buying ...
3d
India’s Piramal Pharma Aims to Double Revenue in Five Years
Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in ...
3d
on MSN
Pharma company funding for patient advocacy groups needs to be transparent, says researcher
Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...
3d
Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH
VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade to ...
MM&M
2d
Real Chemistry strikes partnership with Corval, aiming to tackle biggest challenges in pharma commercialization
The partnership will combine Real Chemistry’s consultative and strategic expertise with Corval’s commercialization planning ...
Hosted on MSN
1d
Dr. Reddy's Laboratories Stock Split: Record Date Fixed! Pharma giant shares to trade ex-date this month
Dr. Reddy’s Laboratories is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984. The stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pfizer
United States
New Jersey
Piramal
Indian rupee
Feedback